Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vital Capacity in SAPB for Rib Fractures
NCT04530149Phase 4Terminated
- Start
- Nov 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in rib fracture. Started Nov 2021; status: terminated.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT04530149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530149.